Nuermberger E - Search Results

1

Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.

Kaushik A, Ammerman NC, Tasneen R, Lachau-Durand S, Andries K, Nuermberger E. Kaushik A, et al. Among authors: nuermberger e. Am J Respir Crit Care Med. 2022 Mar 1;205(5):570-579. doi: 10.1164/rccm.202012-4541OC. Am J Respir Crit Care Med. 2022. PMID: 34939891

2

Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.

Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Nuermberger EL, et al. Am J Respir Crit Care Med. 2004 Feb 1;169(3):421-6. doi: 10.1164/rccm.200310-1380OC. Epub 2003 Oct 24. Am J Respir Crit Care Med. 2004. PMID: 14578218

3

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.

Nuermberger EL, Yoshimatsu T, Tyagi S, Williams K, Rosenthal I, O'Brien RJ, Vernon AA, Chaisson RE, Bishai WR, Grosset JH. Nuermberger EL, et al. Am J Respir Crit Care Med. 2004 Nov 15;170(10):1131-4. doi: 10.1164/rccm.200407-885OC. Epub 2004 Aug 11. Am J Respir Crit Care Med. 2004. PMID: 15306535

4

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.

Tyagi S, Nuermberger E, Yoshimatsu T, Williams K, Rosenthal I, Lounis N, Bishai W, Grosset J. Tyagi S, et al. Among authors: nuermberger e. Antimicrob Agents Chemother. 2005 Jun;49(6):2289-93. doi: 10.1128/AAC.49.6.2289-2293.2005. Antimicrob Agents Chemother. 2005. PMID: 15917523 Free PMC article.

5

Latent tuberculosis infection.

Nuermberger E, Bishai WR, Grosset JH. Nuermberger E, et al. Semin Respir Crit Care Med. 2004 Jun;25(3):317-36. doi: 10.1055/s-2004-829504. Semin Respir Crit Care Med. 2004. PMID: 16088473

6

Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.

Rosenthal IM, Williams K, Tyagi S, Vernon AA, Peloquin CA, Bishai WR, Grosset JH, Nuermberger EL. Rosenthal IM, et al. Am J Respir Crit Care Med. 2005 Dec 1;172(11):1457-62. doi: 10.1164/rccm.200507-1072OC. Epub 2005 Sep 1. Am J Respir Crit Care Med. 2005. PMID: 16141439 Free PMC article.

7

Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.

Nuermberger E, Tyagi S, Williams KN, Rosenthal I, Bishai WR, Grosset JH. Nuermberger E, et al. Am J Respir Crit Care Med. 2005 Dec 1;172(11):1452-6. doi: 10.1164/rccm.200507-1047OC. Epub 2005 Sep 8. Am J Respir Crit Care Med. 2005. PMID: 16151038 Free PMC article.

8

Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.

Rosenthal IM, Williams K, Tyagi S, Peloquin CA, Vernon AA, Bishai WR, Grosset JH, Nuermberger EL. Rosenthal IM, et al. Am J Respir Crit Care Med. 2006 Jul 1;174(1):94-101. doi: 10.1164/rccm.200602-280OC. Epub 2006 Mar 30. Am J Respir Crit Care Med. 2006. PMID: 16574936 Free PMC article.

9

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.

Nuermberger E, Rosenthal I, Tyagi S, Williams KN, Almeida D, Peloquin CA, Bishai WR, Grosset JH. Nuermberger E, et al. Antimicrob Agents Chemother. 2006 Aug;50(8):2621-5. doi: 10.1128/AAC.00451-06. Antimicrob Agents Chemother. 2006. PMID: 16870750 Free PMC article.

10

Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.

Byrne ST, Denkin SM, Gu P, Nuermberger E, Zhang Y. Byrne ST, et al. Among authors: nuermberger e. J Med Microbiol. 2007 Aug;56(Pt 8):1047-1051. doi: 10.1099/jmm.0.47058-0. J Med Microbiol. 2007. PMID: 17644711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters